SG11201601646YA - Deoxynojirimycin derivatives and methods of their using - Google Patents
Deoxynojirimycin derivatives and methods of their usingInfo
- Publication number
- SG11201601646YA SG11201601646YA SG11201601646YA SG11201601646YA SG11201601646YA SG 11201601646Y A SG11201601646Y A SG 11201601646YA SG 11201601646Y A SG11201601646Y A SG 11201601646YA SG 11201601646Y A SG11201601646Y A SG 11201601646YA SG 11201601646Y A SG11201601646Y A SG 11201601646YA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- deoxynojirimycin derivatives
- deoxynojirimycin
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361878286P | 2013-09-16 | 2013-09-16 | |
PCT/US2014/055599 WO2015039010A2 (en) | 2013-09-16 | 2014-09-15 | Deoxynojirimycin derivatives and methods of their using |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201601646YA true SG11201601646YA (en) | 2016-04-28 |
Family
ID=52666528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201601646YA SG11201601646YA (en) | 2013-09-16 | 2014-09-15 | Deoxynojirimycin derivatives and methods of their using |
Country Status (18)
Country | Link |
---|---|
US (1) | US10144727B2 (zh) |
EP (1) | EP3046558B1 (zh) |
JP (1) | JP6456393B2 (zh) |
KR (1) | KR20160055916A (zh) |
CN (1) | CN105636589B (zh) |
AP (1) | AP2016009125A0 (zh) |
AU (1) | AU2014318488B2 (zh) |
BR (1) | BR112016005417A8 (zh) |
CA (1) | CA2924026C (zh) |
CL (1) | CL2016000597A1 (zh) |
CR (1) | CR20160178A (zh) |
HK (1) | HK1222129A1 (zh) |
IL (1) | IL244446A0 (zh) |
MX (1) | MX2016003323A (zh) |
PH (1) | PH12016500465A1 (zh) |
RU (1) | RU2702133C2 (zh) |
SG (1) | SG11201601646YA (zh) |
WO (1) | WO2015039010A2 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3094615A4 (en) | 2014-01-13 | 2017-11-08 | P2 Science, Inc. | Terpene-derived acids and esters and methods for preparing and using same |
JP6687547B2 (ja) | 2014-06-20 | 2020-04-22 | ピー2 サイエンス,インコーポレイティド | 管式又は多管式反応器における膜オゾン分解 |
WO2016022803A2 (en) * | 2014-08-06 | 2016-02-11 | P2 Science, Inc. | Fragrances from the esters of fatty acids |
US10428022B2 (en) | 2014-11-05 | 2019-10-01 | Emergent Virology Llc | Iminosugars useful for the treatment of viral diseases |
WO2017201030A1 (en) * | 2016-05-16 | 2017-11-23 | Emergent Virology Llc | Methods of treating viral infection |
US20190282558A1 (en) * | 2016-05-16 | 2019-09-19 | Emergent Virology Llc | Methods of Treating Zika Virus Infection |
EP3472124A4 (en) | 2016-06-21 | 2020-03-04 | P2 Science, Inc. | CONTINUOUS FLOW REACTORS FOR THE CONTINUOUS EXTINCTION OF PEROXIDE MIXTURES AND METHODS COMPRISING SAME |
US10696605B2 (en) | 2016-09-16 | 2020-06-30 | P2 Science, Inc. | Uses of vanadium to oxidize aldehydes and ozonides |
CN111904959A (zh) * | 2020-08-21 | 2020-11-10 | 牡丹江医学院 | α-L-岩藻糖苷酶抑制剂在制备治疗小儿肺炎的药物中的用途 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2758025A1 (de) * | 1977-12-24 | 1979-07-12 | Bayer Ag | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung |
DE2834122A1 (de) | 1978-08-03 | 1980-02-14 | Bayer Ag | Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose |
DE2853573A1 (de) | 1978-12-12 | 1980-07-03 | Bayer Ag | Herstellung von n-substituierten derivaten des l-desoxynojirimycins |
DE3007078A1 (de) * | 1980-02-26 | 1981-09-10 | Bayer Ag, 5090 Leverkusen | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung |
DE3038901A1 (de) | 1980-10-15 | 1982-05-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins |
DE3611841A1 (de) | 1986-04-09 | 1987-10-15 | Bayer Ag | Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten |
US5103008A (en) | 1989-08-17 | 1992-04-07 | Monsanto Company | Compound, N-butyl-deoxynojirimycin-6-phosphate |
US5043273A (en) | 1989-08-17 | 1991-08-27 | Monsanto Company | Phosphorylated glycosidase inhibitor prodrugs |
US4994572A (en) | 1989-10-12 | 1991-02-19 | Monsanto Company | Synthesis of nojirimycin derivatives |
US5200523A (en) | 1990-10-10 | 1993-04-06 | Monsanto Company | Synthesis of nojirimycin derivatives |
AU1876095A (en) | 1994-02-25 | 1995-09-11 | G.D. Searle & Co. | Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
US20030100532A1 (en) | 1997-02-14 | 2003-05-29 | Gary S. Jacob | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
EP1037636A4 (en) | 1997-12-11 | 2004-08-18 | Univ Oxford | INHIBITATION OF MEMBRANE-TIED VIRAL REPLICATION |
US6689759B1 (en) | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
GB9828474D0 (en) | 1998-12-24 | 1999-02-17 | British Aerospace | Surface topology inspection |
CA2362914C (en) | 1999-02-12 | 2009-04-14 | G.D. Searle & Co. | Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
ES2302697T3 (es) | 1999-08-10 | 2008-08-01 | The Chancellor, Masters And Scholars Of The University Of Oxford | Compuestos n-alquilicos de cadena larga y derivados oxa de los mismos y uso como composiciones antivirales. |
US7256005B2 (en) | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
US7427758B2 (en) | 2003-05-28 | 2008-09-23 | Opto-Knowledge Systems, Inc. | Cryogenically cooled adjustable apertures for infra-red cameras |
FR2861991B1 (fr) * | 2003-11-07 | 2008-01-18 | Centre Nat Rech Scient | Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose |
WO2007140184A2 (en) | 2006-05-24 | 2007-12-06 | United Therapeutics Corporation | Deoxynojirimycin and d-arabinitol analogs and methods of using |
WO2008088581A2 (en) | 2006-08-02 | 2008-07-24 | United Therapeutics Corporation | Liposome treatment of viral infections |
US8097728B2 (en) * | 2007-04-30 | 2012-01-17 | Philadelphia Health & Education Corporation | Iminosugar compounds with antiflavirus activity |
WO2009118658A2 (en) | 2008-03-26 | 2009-10-01 | University Of Oxford | Endoplasmic reticulum targeting liposomes |
US9040488B2 (en) * | 2008-09-02 | 2015-05-26 | Baruch S. Blumberg Institute | Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity |
KR20120042716A (ko) * | 2009-02-23 | 2012-05-03 | 유나이티드 세러퓨틱스 코오포레이션 | 이미노슈가 및 바이러스성 질환을 치료하는 방법 |
ES2562635T3 (es) | 2009-02-24 | 2016-03-07 | United Therapeutics Corporation | Iminoazúcares y métodos de tratamiento de infecciones producidas por arenavirus |
CA2757026A1 (en) | 2009-03-27 | 2010-09-30 | The Chancellor, Masters And Scholars Of The University Of Oxford | Cholesterol level lowering liposomes |
US8426445B2 (en) | 2009-06-12 | 2013-04-23 | United Therapeutics Corporation | Iminosugars and methods of treating bunyaviral and togaviral diseases |
ES2527623T3 (es) | 2009-09-04 | 2015-01-27 | United Therapeutics Corporation | Iminoazúcares para su uso en el tratamiento de enfermedades por filovirus |
WO2011028775A1 (en) * | 2009-09-04 | 2011-03-10 | United Therapeutics Corporation | Methods of treating orthomyxoviral infections |
CN102625801B (zh) | 2009-09-04 | 2015-09-09 | 联合治疗公司 | 治疗痘病毒感染的方法 |
WO2014017915A2 (en) | 2012-07-27 | 2014-01-30 | Universiteit Utrecht Holding B.V. | Urea and guanidinium derivatives of iminosugars |
-
2014
- 2014-09-15 CA CA2924026A patent/CA2924026C/en active Active
- 2014-09-15 KR KR1020167010008A patent/KR20160055916A/ko not_active Application Discontinuation
- 2014-09-15 EP EP14844653.7A patent/EP3046558B1/en active Active
- 2014-09-15 US US15/022,005 patent/US10144727B2/en active Active
- 2014-09-15 CN CN201480050939.7A patent/CN105636589B/zh not_active Expired - Fee Related
- 2014-09-15 WO PCT/US2014/055599 patent/WO2015039010A2/en active Application Filing
- 2014-09-15 RU RU2016111704A patent/RU2702133C2/ru not_active IP Right Cessation
- 2014-09-15 AU AU2014318488A patent/AU2014318488B2/en not_active Ceased
- 2014-09-15 JP JP2016542848A patent/JP6456393B2/ja not_active Expired - Fee Related
- 2014-09-15 BR BR112016005417A patent/BR112016005417A8/pt active Search and Examination
- 2014-09-15 SG SG11201601646YA patent/SG11201601646YA/en unknown
- 2014-09-15 MX MX2016003323A patent/MX2016003323A/es unknown
- 2014-09-15 AP AP2016009125A patent/AP2016009125A0/en unknown
- 2014-09-15 CR CR20160178A patent/CR20160178A/es unknown
-
2016
- 2016-03-06 IL IL244446A patent/IL244446A0/en active IP Right Grant
- 2016-03-10 PH PH12016500465A patent/PH12016500465A1/en unknown
- 2016-03-14 CL CL2016000597A patent/CL2016000597A1/es unknown
- 2016-09-01 HK HK16110378.3A patent/HK1222129A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20160221993A1 (en) | 2016-08-04 |
HK1222129A1 (zh) | 2017-06-23 |
WO2015039010A3 (en) | 2015-05-07 |
KR20160055916A (ko) | 2016-05-18 |
JP6456393B2 (ja) | 2019-01-23 |
PH12016500465B1 (en) | 2016-05-16 |
RU2702133C2 (ru) | 2019-10-04 |
BR112016005417A8 (pt) | 2020-02-18 |
IL244446A0 (en) | 2016-04-21 |
CA2924026A1 (en) | 2015-03-19 |
CN105636589B (zh) | 2019-07-23 |
RU2016111704A3 (zh) | 2018-06-09 |
CL2016000597A1 (es) | 2017-02-24 |
CA2924026C (en) | 2021-12-28 |
PH12016500465A1 (en) | 2016-05-16 |
AP2016009125A0 (en) | 2016-04-30 |
AU2014318488A1 (en) | 2016-04-21 |
EP3046558A4 (en) | 2017-06-07 |
AU2014318488A2 (en) | 2016-04-28 |
US10144727B2 (en) | 2018-12-04 |
MX2016003323A (es) | 2016-08-12 |
CN105636589A (zh) | 2016-06-01 |
AU2014318488B2 (en) | 2019-03-07 |
EP3046558A2 (en) | 2016-07-27 |
CR20160178A (es) | 2016-08-08 |
RU2016111704A (ru) | 2017-10-23 |
WO2015039010A2 (en) | 2015-03-19 |
JP2016530332A (ja) | 2016-09-29 |
EP3046558B1 (en) | 2019-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255037A1 (zh) | 製備烟酰胺核苷和其衍生物的方法 | |
GB2535360B (en) | Methods of preparing polyhemiaminals and polyhexahydrotriazines | |
HK1217428A1 (zh) | 取代的苯並噁唑及其使用方法 | |
IL241512A0 (en) | Pharmaceutical preparations containing glycosidase inhibitors and their preparation | |
IL286759A (en) | Therapeutic methods and preparations | |
EP3065875A4 (en) | Bioprinter and methods of using same | |
HK1221611A1 (zh) | 維持和改善肌肉功能的方法 | |
HK1212977A1 (zh) | 苯達莫司汀衍生物及其使用方法 | |
HK1222129A1 (zh) | 脱氧野尻霉素衍生物及其使用方法 | |
EP2999474A4 (en) | THERAPEUTIC AND METHOD OF USE | |
GB201320723D0 (en) | Composition and methods of treatment | |
EP2964235A4 (en) | ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE | |
IL244268A0 (en) | Heterocyclic compounds and methods of use | |
HK1209324A1 (zh) | 納米酶、製備納米酶的方法、以及使用納米酶的方法 | |
IL244084A0 (en) | New derivatives of onzialamycin and methods for their synthesis | |
PL3019477T3 (pl) | Związki heterocykliczne i sposoby ich stosowania | |
HK1224307A1 (zh) | 原毒素- 變體及其使用方法 | |
IL245272A0 (en) | pif-transfected cells and methods of use | |
IL240695A0 (en) | nme inhibitors and methods of using nme inhibitors | |
KR102377615B1 (ko) | 장치 및 사용 방법 | |
HUE041663T2 (hu) | Myxopyronin és származékai elõállítása | |
GB201319255D0 (en) | Therapeutic compositions and methods | |
GB201322508D0 (en) | Dental frameworks and related methods | |
AU2013902711A0 (en) | Compounds and methods of their use - IV | |
GB201310349D0 (en) | Composition and method of use thereof |